Jan Bornschein
Researcher Next ID · RN-028597
Researcher · Medicine
Oxford, Latvia
- Works count
- 220
- Citation count
- 5,409
- H-index
- 39
- i10-index
- 80
Research interests
Publications
Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025
Endoscopy · 2025 · https://doi.org/10.1055/a-2529-5025
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions
Gut · 2025 · 10.1136/gutjnl-2025-335523
The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
Cellular and Molecular Gastroenterology and Hepatology · 2021 · 10.1016/j.jcmgh.2021.08.013
Identification of Subtypes of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data
Gastroenterology · 2020 · 10.1053/j.gastro.2020.01.044
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals
Nature Immunology · 2020 · https://doi.org/10.1038/s41590-020-0770-x
S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL
Zeitschrift für Gastroenterologie · 2019 · 10.1055/a-1018-2516
Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts
Gastroenterology · 2018 · 10.1053/j.gastro.2018.08.036
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma
British journal of surgery · 2017 · 10.1002/bjs.10627
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
Nature Genetics · 2016 · https://doi.org/10.1038/ng.3659
Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma
Nature Genetics · 2015 · https://doi.org/10.1038/ng.3357
Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
BMC Gastroenterology · 2014 · https://doi.org/10.1186/1471-230x-14-117
Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure ofHelicobacter pyloriinfection
World Journal of Gastroenterology · 2014 · 10.3748/wjg.v20.i43.16245
Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies
European Journal of Gastroenterology & Hepatology · 2013 · 10.1097/meg.0b013e3283643491
Serological assessment of gastric mucosal atrophy in gastric cancer
BMC Gastroenterology · 2012 · 10.1186/1471-230x-12-10
Gastric carcinogenesis
Langenbeck s Archives of Surgery · 2011 · 10.1007/s00423-011-0810-y
S3-Leitlinie „Magenkarzinom” -
Zeitschrift für Gastroenterologie · 2011 · 10.1055/s-0031-1273201
Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians
BMC Medical Genetics · 2011 · 10.1186/1471-2350-12-112
H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer
Digestive Diseases and Sciences · 2010 · 10.1007/s10620-010-1351-x
S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit” der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)
Zeitschrift für Gastroenterologie · 2009 · https://doi.org/10.1055/s-0028-1109062
Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors
Digestive Diseases · 2009 · https://doi.org/10.1159/000218339
Evolution of the Diffuse Neuroendocrine System – Clear Cells and Cloudy Origins
Neuroendocrinology · 2006 · 10.1159/000096997
Current projects
No projects listed.